Palpebral Pathologies

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Thea Pharma
Thea PharmaMA - Waltham
1 program
Management of Eyelid Disorders by Ophthalmologists in Usual Medical PracticeN/A1 trial
Active Trials
NCT01552174CompletedEst. Apr 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Thea PharmaManagement of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

Clinical Trials (1)

NCT01552174Thea PharmaManagement of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

Start: Mar 2012Est. completion: Apr 2014
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space